Insomnia

Short sleep duration, with and without self-reported insomnia, was predictive of elevated blood pressure and hypertension among adolescents, a speaker reported.

Genetic predisposition to traits such as depressive affect, neuroticism and insomnia appeared significantly associated with greater risk for treatment-resistant depression, according to a study published in JAMA Psychiatry.

Inappropriate use of medication for insomnia was prevalent among adults in Canada, particularly those aged older than 65 years, with extended duration of use the most common reason and benzodiazepines the most common drug, new data show.

A voice-activated, in-home cognitive behavioral therapy program alleviated symptoms of insomnia among breast cancer survivors, according to results of a randomized clinical trial.

Benzodiazepines were associated with increased risk for CHD, HF and CV mortality among patients with insomnia, according to a study published in the European Journal of Preventive Cardiology.

Currently, cognitive behavioral therapy for insomnia is the gold standard treatment for sleep disturbances associated with menopause, and research is underway to better target neurons responsible for sleep disturbances.